Osteoarthritis is the most common form of arthritis and affects millions of people worldwide.
It develops when the protective cartilage that cushions the ends of bones gradually wears away.
As the cartilage becomes thinner, bones rub against each other, causing pain, stiffness, swelling, and reduced movement that can make everyday activities difficult.
Although treatments such as exercise, physical therapy, pain medicines, and joint replacement surgery can improve symptoms, they do not stop or reverse the damage to cartilage. Scientists have therefore been searching for ways to repair the tissue instead of simply relieving pain.
A research team at the University of Southern California has now uncovered a promising biological pathway that may one day help restore damaged cartilage.
Their study focused on a protein called Signal Transducer and Activator of Transcription 3, or STAT3, which appears to play a major role in keeping cartilage cells healthy.
Cartilage is maintained by specialised cells called chondrocytes. As people age, these cells gradually lose their ability to repair damaged tissue, making cartilage weaker and less able to protect the joints. This process contributes to the slow development of osteoarthritis.
The researchers discovered that activating STAT3 made aging cartilage cells behave more like younger cells. After STAT3 was switched on, the cells regained many features associated with healthy cartilage and showed a greater ability to maintain and repair joint tissue.
The team also studied the epigenetic clock, which measures chemical changes that occur as cells grow older without changing the DNA itself. These changes influence how genes work and provide a way to estimate the biological age of cells. Activating STAT3 reversed many of these age-related changes, suggesting that the cells had become biologically younger.
In contrast, turning off STAT3 caused cartilage cells to age more quickly. The researchers also found that another enzyme, called DNA methyltransferase 3 beta, or DNMT3B, contributed to cartilage damage when STAT3 was inactive. In mouse experiments, this combination led to more severe osteoarthritis after joint injury.
Interestingly, damaged cartilage still attempted to repair itself by producing new cells. However, the newly formed cartilage was not strong enough to restore normal joint function, showing that successful repair requires both regeneration and healthy cell activity.
These findings suggest that therapies targeting STAT3 could eventually help slow, stop, or even reverse some of the damage caused by osteoarthritis. Such treatments might reduce the need for long-term pain medication and delay or prevent joint replacement surgery for some patients.
The researchers caution that the work is still at an early stage. One major challenge is finding a way to activate STAT3 safely without triggering unwanted inflammation, which could worsen joint damage. More laboratory studies and human clinical trials will be needed before this approach can become a treatment.
This research provides an exciting new direction in osteoarthritis science because it focuses on restoring the health of cartilage cells instead of simply treating symptoms. The study’s strengths include identifying a specific biological target and demonstrating its effects in both cells and animal models.
However, it remains preclinical research, so it is too early to know whether the same benefits will occur in people. If future studies are successful, this strategy could transform osteoarthritis care by helping damaged joints repair themselves rather than only managing pain.
If you care about health, please read studies that plant-based diets can harm your bone health without these nutrients, and how to ease arthritis with anti-inflammatory foods.
For more health information, please see recent studies that too much of this vitamin may increase your risk of bone fractures, and results showing this type of exercise may protect your bone health, slow down bone aging.
Copyright © 2026 Knowridge Science Report. All rights reserved.
